Oral ONC201 in Recurrent GBM, H3 K27M Glioma, and Midline Glioma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 30
Summary
- Conditions
- Basal Ganglia Glioma
- Diffuse Midline Glioma
- Glioblastoma
- H3 K27M Glioma
- Infratentorial Glioma
- Thalamic Glioma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 16 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02525692
- Collaborators
- Not Provided
- Investigators
- Not Provided
Get Well Soon